W M Kast - JoVE Visualize

Showing results (81-90 of 128) with videos related to

Pageof 13

Sort By:

Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1995

An adenovirus type 5 early region 1B-encoded CTL epitope-mediating tumor eradication by CTL clones is down-modulated by an activated ras oncogeneR E Toes, R Offringa, R J Blom, et al.

Nature|April 25, 1991

Peptide selection by MHC class I moleculesT N Schumacher, M L De Bruijn, L N Vernie, et al.

Human Immunology|December 1, 1995

An HLA class I peptide-binding assay based on competition for binding to class I molecules on intact human B cells. Identification of conserved HIV-1 polymerase peptides binding to HLA-A*0301S H van der Burg, E Ras, J W Drijfhout, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2000

A phase I trial of a human papillomavirus (HPV) peptide vaccine for women with high-grade cervical and vulvar intraepithelial neoplasia who are HPV 16 positiveL Muderspach, S Wilczynski, L Roman, et al.

Cancer Research|July 29, 1998

Efficient direct priming of tumor-specific cytotoxic T lymphocyte in vivo by an engineered APCS P Schoenberger, L E Jonges, R J Mooijaart, et al.

Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 10, 1998

Peptide vaccination with an anchor-replaced CTL epitope protects against human papillomavirus type 16-induced tumors expressing the wild-type epitopeM P Vierboom, M C Feltkamp, A Neisig, et al.

Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1989

Lack of correlation between levels of MHC class I antigen and susceptibility to lysis of small cellular lung carcinoma (SCLC) by natural killer cellsN J Stam, W M Kast, A C Voordouw, et al.

Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1995

CTL specific for the tyrosinase autoantigen can be induced from healthy donor blood to lyse melanoma cellsM J Visseren, A van Elsas, E I van der Voort, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 1996

Decreased expression of signal-transducing zeta chain in peripheral T cells and natural killer cells in patients with cervical cancerK Kono, M E Ressing, R M Brandt, et al.

Biological Chemistry|May 1, 1999

Induction of HPV16 capsid protein-specific human T cell responses by virus-like particlesM P Rudolf, J D Nieland, D M DaSilva, et al.

Pageof 13

Showing results (81-90 of 128) with videos related to

Sort By:

Pageof 13

Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1995

An adenovirus type 5 early region 1B-encoded CTL epitope-mediating tumor eradication by CTL clones is down-modulated by an activated ras oncogeneR E Toes, R Offringa, R J Blom, et al.

Nature|April 25, 1991

Peptide selection by MHC class I moleculesT N Schumacher, M L De Bruijn, L N Vernie, et al.

Human Immunology|December 1, 1995

An HLA class I peptide-binding assay based on competition for binding to class I molecules on intact human B cells. Identification of conserved HIV-1 polymerase peptides binding to HLA-A*0301S H van der Burg, E Ras, J W Drijfhout, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2000

A phase I trial of a human papillomavirus (HPV) peptide vaccine for women with high-grade cervical and vulvar intraepithelial neoplasia who are HPV 16 positiveL Muderspach, S Wilczynski, L Roman, et al.

Cancer Research|July 29, 1998

Efficient direct priming of tumor-specific cytotoxic T lymphocyte in vivo by an engineered APCS P Schoenberger, L E Jonges, R J Mooijaart, et al.

Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 10, 1998

Peptide vaccination with an anchor-replaced CTL epitope protects against human papillomavirus type 16-induced tumors expressing the wild-type epitopeM P Vierboom, M C Feltkamp, A Neisig, et al.

Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1989

Lack of correlation between levels of MHC class I antigen and susceptibility to lysis of small cellular lung carcinoma (SCLC) by natural killer cellsN J Stam, W M Kast, A C Voordouw, et al.

Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1995

CTL specific for the tyrosinase autoantigen can be induced from healthy donor blood to lyse melanoma cellsM J Visseren, A van Elsas, E I van der Voort, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 1996

Decreased expression of signal-transducing zeta chain in peripheral T cells and natural killer cells in patients with cervical cancerK Kono, M E Ressing, R M Brandt, et al.

Biological Chemistry|May 1, 1999

Induction of HPV16 capsid protein-specific human T cell responses by virus-like particlesM P Rudolf, J D Nieland, D M DaSilva, et al.

Pageof 13